Events

Events

2017

February 23-25, 2017

ASCO-SITC Clinical Immuno-Oncology Symposium

Orlando, Florida

Stephen J Russell from Vyriad was invited to present on "Viral Therapy" at the ASCO-SITC conference on exploiting viruses for cancer therapy in combination with immune modulators.

2016

October 1-4, 2016

the 10th International Meeting on Replicating Oncolytic Virus Therapeutics

Vancouver, Canada

Kah-Whye Peng, PhD, CTO of Vyriad gave a Plenary presentation entitled “Vesicular stomatitis virus (VSV) as an oncolytic agent”

Stephen J. Russell, MD, PhD, CEO & President of Vyriad gave a Plenary presentation entitled “Measles as a versatile oncolytic agent”
June 18, 2016

35th Annual Meeting of the American Society of Virology

Blacksburg, VA

Keynote Lecture: “Oncolytic Viruses: Past, Present, and Future”

Stephen J. Russell, MD, PhD, CEO & President, Vyriad